Population Based Germline Testing for Early Detection and Prevention of Cancer

NCT07498829 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

6000

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Risk
Ovarian Cancer Risk
Cancer Gene Mutation

Interventions

GENETIC: Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) and personalised breast and ovarian cancer risk

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]